(BY MR. BLASIER) When stains 30 and 31 were processed, there was such a small amount of DNA, they couldn't do RFLP testing on it, correct?
And it was only after two months later, in August, did they go back and find, lo and behold, a lot more DNA, correct?
BY MR. BLASIER: In 303, 304, 305, which were collected on August 29, there is a lot more DNA than there was in the original stains, correct?
(BY MR. BLASIER) Now, your testimony about the RFLP results only related to DNA consistent with the victims, correct?
The only DNA found on the Rockingham glove consistent with Mr. Simpson were extremely small amounts of DNA in the wrist area, correct?
And these gloves -- this glove was handled right after Mr. Yamauchi opened Mr. Simpson's reference vial, correct?
And Mr. Yamauchi testified at the criminal trial that he didn't remember changing his gloves between opening the reference vial and processing that glove. Do you recall that.
Objection. Calls for hearsay, what he testified to -- somebody else testified to at the criminal trial.
You can rephrase that.
I'll sustain the objection.
You may ask him if that was a factor that he considered.
(BY MR. BLASIER) Was it a factor that you considered in deciding that Mr. Simpson's -- or blood consistent with Mr. Simpson on the Rockingham glove came from possible cross-contamination, the packet that Collin Yamauchi testified in the criminal trial, he didn't know whether he changed his gloves?
And the areas it, the wrist areas where those stains were found, were areas that were handled by Mr. Yamauchi with his hands, right after opening Mr. Simpson's reference blood, correct?
And you're aware of the testimony? You relied on the testimony of Mr. Yamauchi that the blood came out of that reference tube, onto his gloves, and his chemwipes, correct?
Now, you gave some testimony with respect to cross-contamination happening sometimes. You'll see evidence of more than one person as evidence of contamination incident, that's what you saw on 30 and 31, correct?
And sometimes you may only see evidence of one person. And tell me the example where that could happen?
That would be possible, certainly, if you had two homozygous individuals, the combining of those two would be, actually look -- appear to be one person, but it's actually from two.
Excessively degraded samples would be an example where the initial sample is so degraded, that the second contaminating DNA over -- over -- well, the original type, and all you see is the contaminant.
KEY QUOTENow, from the results that Mr. Yamauchi got on the 14 and 15 from the Bundy swatches, you cannot conclude from that anything about the source of the blood on those swatches, can you?
Mr. Lambert asked you questions about transfers of DNA, and you mentioned something about glasses.
Do you recall reviewing the videotapes of Andrea Mazzola collecting evidence at the Rockingham crime scene?
Did you make any observation about her collection technique, vis-a-vis, her glasses in that video?
Yes. There's a sequence there where she actually does take a glove and adjusts her glasses with her gloved hand and adjusts her glasses.
KEY QUOTENow, Mr. Lambert asked you what was your basis for concluding that item 52 might be the result of cross-contamination.
Did you state everything that you considered in making that assessment?
Now, he also asked you about validation studies.
Every case that you look at, you look at validation studies of the laboratory that you're looking at, correct.
BY MR. BLASIER: Now, you were asked about forensic testing, and you don't run a forensic lab correct?
Now, the technology that's used by crime labs is technology that came from the clinical setting, in the medical setting that you work in, correct?
The fundamental science is molecular biology. Then it goes to the clinical field. And then it goes to forensics. Usually that's the way it goes, yes.
In the forensic community, they didn't develop any of the fundamental sciences in just forensics?
And would you agree that one of the critiques of the forensic community is the lack of controls that they have in terms of sample collection, preparation, contamination controls, et cetera?
(BY MR. BLASIER) Forensic labs that do this for a business, generally come in and say it's okay, don't they?
From all of the techniques that are used in forensics that you've testified here about, are techniques that were used previously, or for longer periods of time in the clinical setting that you do your work in, correct?
And all of the issues that you talked about, contamination and sample processing, are all extremely important issues in the work that you do every single day, correct?
And in your opinion, do you need to be a forensic scientist in order to have any knowledge about DNA technology, as you do in your clinical lab?
In fact, in the 35 times that you've testified, this is always brought up, that you have a clinical lab and not a forensic lab; is that correct?
There's a sequence there where she actually does take a glove and adjusts her glasses with her gloved hand and adjusts her glasses.
Excessively degraded samples would be an example where the initial sample is so degraded, that the second contaminating DNA over -- over -- well, the original type, and all you see is the contaminant.
I believe she testified that she does not go to crime scenes, so I would say none.
Yes. That's true.